Advances in personalized medicine for lung cancer: What's in it for the patient

Birgitta Hiddinga

doi:10.33612/diss.1004972626

Advances in personalized medicine for lung cancer: What's in it for the patient

Birgitta Hiddinga

Research output: Thesis › Thesis fully internal (DIV)

657 Downloads (Pure)

Abstract

This thesis is a plea for finding and using biomarkers, to enhance precision medicine in the treatment of lung cancer patients, and a plea for speeding up the process towards precision medicine (or targeted therapy), because of the obvious benefits that will bring for patients and physicians, such asreducing ineffective therapies and medication.

Original language	English
Qualification	Doctor of Philosophy
Awarding Institution	University of Groningen
Supervisors/Advisors	Slebos, Dirk Jan, Supervisor van Meerbeeck, Jan P., Supervisor, External person
Award date	15-May-2024
Place of Publication	[Groningen]
Publisher	University of Groningen
DOIs	https://doi.org/10.33612/diss.1004972626
Publication status	Published - 2024

Access to Document

10.33612/diss.1004972626

Title and contentsFinal publisher's version, 1.76 MB
Chapter 1Final publisher's version, 4 MB
Chapter 2Final publisher's version, 1.83 MB
Chapter 3Final publisher's version, 1.69 MB
AddendumFinal publisher's version, 1.76 MB
Chapter 4Final publisher's version, 1.85 MB
Chapter 5Final publisher's version, 2.7 MB
Chapter 6Final publisher's version, 7 MB
Chapter 7Final publisher's version, 12.9 MB
Chapter 8Final publisher's version, 4.04 MB
Chapter 9Final publisher's version, 2.59 MB
Chapter 10Final publisher's version, 1.81 MB
Hoofdstuk 11Final publisher's version, 1.8 MB
AppendicesFinal publisher's version, 1.78 MB
Complete thesisFinal publisher's version, 26.1 MB
PropositionsFinal publisher's version, 1.51 MB

Handle.net

Persistent link

Cite this

@phdthesis{3fb461a6dce14ff7a40e245b9da4a938,

title = "Advances in personalized medicine for lung cancer: What's in it for the patient",

abstract = "This thesis is a plea for finding and using biomarkers, to enhance precision medicine in the treatment of lung cancer patients, and a plea for speeding up the process towards precision medicine (or targeted therapy), because of the obvious benefits that will bring for patients and physicians, such asreducing ineffective therapies and medication.",

author = "Birgitta Hiddinga",

year = "2024",

doi = "10.33612/diss.1004972626",

language = "English",

publisher = "University of Groningen",

school = "University of Groningen",

}

TY - BOOK

T1 - Advances in personalized medicine for lung cancer

T2 - What's in it for the patient

AU - Hiddinga, Birgitta

PY - 2024

Y1 - 2024

N2 - This thesis is a plea for finding and using biomarkers, to enhance precision medicine in the treatment of lung cancer patients, and a plea for speeding up the process towards precision medicine (or targeted therapy), because of the obvious benefits that will bring for patients and physicians, such asreducing ineffective therapies and medication.

AB - This thesis is a plea for finding and using biomarkers, to enhance precision medicine in the treatment of lung cancer patients, and a plea for speeding up the process towards precision medicine (or targeted therapy), because of the obvious benefits that will bring for patients and physicians, such asreducing ineffective therapies and medication.

U2 - 10.33612/diss.1004972626

DO - 10.33612/diss.1004972626

M3 - Thesis fully internal (DIV)

PB - University of Groningen

CY - [Groningen]

ER -

Advances in personalized medicine for lung cancer: What's in it for the patient

Abstract

Access to Document

Handle.net

Fingerprint

Cite this